MISSISSAUGA, ONTARIO--(CCNMatthews - Nov. 14, 2006) - BioSyent Inc. (“BioSyent”)(TSX VENTURE:RX) today released its third quarter 2006 financial results. Sales for the quarter ended September 30, 2006 were $627,244 up 153% compared to the same period in 2005 ($248,383). Net Income for the quarter increased 411%, from $59,355 in the 3rd. Quarter, 2005, to $ 303,590 in the comparable quarter in 2006. The increase in sales was mainly due to increased Canadian orders of Protect-It®. Sales for the nine months ended September, 2006, were $1,040,608, up 90% from the corresponding period in the previous year ($548,643). The net profit from operations for the first nine months of 2006 was $296,491 compared to a loss of (-$20,052) incurred in the comparative period in 2005. Net Income for the nine months ending 30th., September 2006 of $296,491, was however, less than that reported for the previous year period ($585,604), which included a one time gain of $ 605,656 on account of the return of INSTI® distribution rights in 2005.
